Search This Blog

Wednesday, August 7, 2019

ANI Pharmaceuticals EPS beats by $0.16, misses on revenue

ANI Pharmaceuticals (NASDAQ:ANIP): Q2 Non-GAAP EPS of $1.44 beats by $0.16; GAAP EPS of $0.53 beats by $0.01.
Revenue of $54.36M (+15.0% Y/Y) misses by $0.84M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)